![Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic | Journal for ImmunoTherapy of Cancer | Full Text Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic | Journal for ImmunoTherapy of Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40425-018-0394-y/MediaObjects/40425_2018_394_Fig4_HTML.png)
Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic | Journal for ImmunoTherapy of Cancer | Full Text
![Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic | Journal for ImmunoTherapy of Cancer Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/6/1/89/F2.large.jpg)
Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic | Journal for ImmunoTherapy of Cancer
![Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic | Journal for ImmunoTherapy of Cancer | Full Text Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic | Journal for ImmunoTherapy of Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40425-018-0394-y/MediaObjects/40425_2018_394_Fig1_HTML.png)
Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic | Journal for ImmunoTherapy of Cancer | Full Text
![PDF) Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic PDF) Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic](https://i1.rgstatic.net/publication/327605025_Alpha-fetoprotein_AFP_as_tumor_marker_in_a_patient_with_urothelial_cancer_with_exceptional_response_to_anti-PD-1_therapy_and_an_escape_lesion_mimic/links/5b994f47458515310583dd7b/largepreview.png)
PDF) Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic
![PDF) Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic PDF) Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic](https://www.researchgate.net/publication/327605025/figure/fig1/AS:670092824158222@1536773987942/a-H-E-staining-of-the-primary-urothelial-tumor-40X-magnification-b_Q320.jpg)
PDF) Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic
![Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/f77de667-2a9f-4ec7-b98c-de3c62b2f4b4/gr2_lrg.jpg)